Clinical evaluation on idiopathic pulmonary fibrosis.
10.11817/j.issn.1672-7347.2021.190402
- Author:
Qinxue SHEN
1
;
Hong PENG
2
Author Information
1. Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha 410011, China. 188211012@csu.edu.cn.
2. Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha 410011, China. penghong66@csu.edu.cn.
- Publication Type:Journal Article
- Keywords:
evaluation;
health-related quality of life;
idiopathic pulmonary fibrosis;
imaging;
laboratory examination;
multi-dimensional assessment system;
physiological function
- MeSH:
Humans;
Idiopathic Pulmonary Fibrosis/diagnosis*;
Quality of Life
- From:
Journal of Central South University(Medical Sciences)
2021;46(3):309-315
- CountryChina
- Language:English
-
Abstract:
Idiopathic pulmonary fibrosis (IPF) is a chronic fatal pulmonary disease characterized by complex illness condition. There is no effective treatment at present except lung transplantation. The comprehensive evaluation is helpful for the management of patients with IPF in hierarchical stages. Therefore, it is very important to evaluate IPF by various independent factors. At present, the commonly used methods for clinical evaluation on IPF include assessment of health-related quality of life, assessment of physiological function, assessment of imaging, assessment of laboratory examination, and multi-dimensional assessment system. However, there are different advantages and disadvantages on diverse evaluation methods for the evaluation of IPF.
